Ausgabe 2/2001
Inhalt (8 Artikel)
Generation of human anti-MUC3 IgG antibodies after in vitro immunization of naive peripheral blood B-lymphocytes
Stavroula Baritaki, Alexandros Zafiropoulos, Eustathia Georgopoulou, Sotirios Souris, Elias Krambovitis
Expression of L-selectin and efficient binding to high endothelial venules do not modulate the dissemination potential of murine B-cell lymphoma
Ronit Aviram, Nava Raz, Tova Kukulansky, Nurit Hollander
Tributyrin enhances the cytotoxic activity of interleukin-2/interleukin-12 stimulated human natural killer cells against LS 174T colon cancer cells in vitro
Claudia P. Schröder, H. Rainer Maurer
Active idiotypic vaccination in a patient with biclonal follicular lymphoma
Yvelise Barrios, Aresio Plaza, Rafael Cabrera, Rosa Yáñez, Eduardo Suárez, Manuel Nicolás Fernández, Fernando Díaz-Espada
Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo system
Christoph Renner, Ingo Stehle, Fook Thean Lee, Cathrine Hall, Bruno Catimel, Edouard C. Nice, Angela Mountain, Angela Rigopoulos, Martin W. Brechbiel, Michael Pfreundschuh, Andrew M. Scott
Human scFv antibody fragments specific for the epithelial tumour marker MUC-1, selected by phage display on living cells
Cindy Wong, Robert Waibel, Michael Sheets, Jean-Pierre Mach, Ricarda Finnern
Long-term treatment with low doses of interleukin-2 and interferon-α: immunological effects in advanced renal cell cancer
Laura Pavone, Simeone Andrulli, Rosaria Santi, Maria Majori, Carlo Buzio
Relationship between tumour morphology, antigen and antibody distribution measured by fusion of digital phosphor and photographic images
Aiden A. Flynn, Geoffrey M. Boxer, Richard H. J. Begent, R. Barbara Pedley